Sort
82,697 grants matching “vaccine development”
CoVPN 3008 2022-2023
$12,647,369Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$12,612,766Joseph E Robertson · Oregon Health & Science University · P51 · FY2015 · OD
Production of a Broadly Neutralizing HIV Antibodies
$12,600,129Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2021 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$12,509,936Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2020 · AI
Region VI Center for Biodefence and Emerging Infections
$12,477,542University Of Texas Medical Br Galveston · U54 · FY2005 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$12,444,772Joseph E Robertson · Oregon Health & Science University · P51 · FY2009 · RR
NIAID Centers of Excellence for Influenza Research and Response
$12,408,897Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2024 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$12,403,452Joseph E Robertson · Oregon Health & Science University · P51 · FY2013 · OD
RII Track-1: Building Capacity across Iowa to Meet Human Needs from Things that Grow
$12,395,035Laura R Jarboe · Iowa State University · · FY2023 · O/D
Leadership for HIV/AIDS Clinical Trials Networks; HIV Vaccine Trials Network
$12,347,128Steven G. Self · Fred Hutchinson Cancer Research Center · U01 · FY2010 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$12,345,633Peter Gordon Gillespie · Oregon Health & Science University · P51 · FY2017 · OD
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$12,275,590Ted Ross · University Of Georgia · N01 · FY2021 · AI
Advancing genomic, transcriptomic and functional approaches to combat globally important and emerging pathogens
$12,121,843Daniel E Neafsey · Broad Institute, Inc. · U19 · FY2024 · AI
THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOP
$12,110,276John Eldridge · Profectus Biosciences, Inc. · N01 · FY2009 · AI
Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery
$12,037,011Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2018 · AI
NIAID Global Collaborative for TB Research and Development
$12,000,000Chris Maxwell · National Institute Of Allergy And Infectious Diseases · Y01 · FY2022 · AI
NEW HORIZONS IN THE PREVENTION AND TREATMENT OF FOOD ALLERGY
$11,982,118Robert A Wood · Johns Hopkins University · UM2 · FY2022 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM
$11,979,672Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2020 · AI
Regional Biocontainment Laboratory (RBL)
$11,970,523Duke University · UC6 · FY2003 · AI
Moodeling Immunity for Biodefense: influenza virus
$11,916,323Hulin Wu · University Of Rochester · N01 · FY2010 · AI
New England Regional Center of Excellence for Biodefens*
$11,843,830Harvard University (Medical School) · U54 · FY2004 · AI
Discovering Durable Pan-Coronavirus Immunity
$11,809,995Duane R. Wesemann · Brigham And Women'S Hospital · P01 · FY2021 · AI
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group
$11,785,053J Brooks Jackson · Johns Hopkins University · UM1 · FY2013 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA RESEARCH
$11,756,332Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2022 · AI
Development/production of universal influenza vaccines
$11,743,293Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2014 · AI